<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: OptiBiotix Health shares in free-fall despite operational progress	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Mon, 09 Dec 2019 14:15:08 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: OptiBiotix shares dip despite Filipino distribution agreement - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/#comment-13088</link>

		<dc:creator><![CDATA[OptiBiotix shares dip despite Filipino distribution agreement - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 09 Dec 2019 14:15:08 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=21591#comment-13088</guid>

					<description><![CDATA[[&#8230;] firm has seen a mixed few months of trading, as it saw its shares crash at the end of August despite gaining new licences and partnerships during the first half of the [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] firm has seen a mixed few months of trading, as it saw its shares crash at the end of August despite gaining new licences and partnerships during the first half of the [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Yourgene set to hit growth target in half year update - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/#comment-12048</link>

		<dc:creator><![CDATA[Yourgene set to hit growth target in half year update - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 14 Oct 2019 13:45:47 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=21591#comment-12048</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates on Ra Pharmaceuticals Inc (NASDAQ: RARX),  OptiBiotix Health Plc (LON: OPTI) and NMC Health (LON: [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates on Ra Pharmaceuticals Inc (NASDAQ: RARX),  OptiBiotix Health Plc (LON: OPTI) and NMC Health (LON: [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Deltex Medical shares dip as revenues narrow - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/#comment-11756</link>

		<dc:creator><![CDATA[Deltex Medical shares dip as revenues narrow - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 23 Sep 2019 08:11:00 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=21591#comment-11756</guid>

					<description><![CDATA[[&#8230;] (AMS: CURE), Integumen PLC (LON: SKIN), Medica Group PLC (LON: MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC) and Astrazeneca plc (LON: [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] (AMS: CURE), Integumen PLC (LON: SKIN), Medica Group PLC (LON: MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC) and Astrazeneca plc (LON: [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Curetis finds a salve for its losses as revenues hike 35% - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/#comment-11711</link>

		<dc:creator><![CDATA[Curetis finds a salve for its losses as revenues hike 35% - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 18 Sep 2019 13:30:17 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=21591#comment-11711</guid>

					<description><![CDATA[[&#8230;] updates from; Integumen PLC (LON: SKIN), Medica Group PLC (LON: MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] updates from; Integumen PLC (LON: SKIN), Medica Group PLC (LON: MGP), EMIS Group (LON: EMIS), OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: EMIS Group revenue and profit growth pull up dividends and EPS - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/optibiotix-health-shares-in-free-fall-despite-operational-progress/#comment-11453</link>

		<dc:creator><![CDATA[EMIS Group revenue and profit growth pull up dividends and EPS - UK Investor Magazine]]></dc:creator>
		<pubDate>Fri, 30 Aug 2019 10:56:21 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=21591#comment-11453</guid>

					<description><![CDATA[[&#8230;] in health and medical news, there have been updates from; OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] in health and medical news, there have been updates from; OptiBiotix Health PLC (LON: OPTI)  NMC Health (LON: NMC), Astrazeneca plc (LON: AZN) [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
